These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2198414)

  • 21. [Histological progression of paucibacillary leprosy during treatment with various therapeutic regimens].
    Pattyn SR; Husser JA; Janssens L; Nollet E
    Acta Leprol; 1986; 4(4):501-4. PubMed ID: 3296623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short course treatment of paucibacillary (TT/BT) leprosy cases.
    Girdhar BK; Girdhar A; Ramu G; Desikan KV
    Indian J Lepr; 1985; 57(3):491-8. PubMed ID: 3831086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
    Koranne RV; Srivastava G
    Indian J Lepr; 1988 Jan; 60(1):90-2. PubMed ID: 3060548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampicin for lepromatous leprosy: nine years' experience.
    Waters MF; Rees RJ; Pearson JM; Laing AB; Helmy HS; Gelber RH
    Br Med J; 1978 Jan; 1(6106):133-6. PubMed ID: 339995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
    Katoch K; Ramu G; Ramanathan U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

  • 34. Rifampin therapy of lepromatous leprosy.
    Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inadequate treatment in multibacillary leprosy and incubation times for relapses].
    Pattyn SR; Husser JA; Janssens L; Grillone S; Bourland J
    Acta Leprol; 1986; 4(4):495-9. PubMed ID: 3296622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug therapy in paucibacillary leprosy--a five year experience.
    Grugni A; Nadkarni NJ; Kini MS
    Indian J Lepr; 1988 Oct; 60(4):589-92. PubMed ID: 3253339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.
    Pieters FA; Woonink F; Zuidema J
    Eur J Clin Pharmacol; 1988; 34(1):73-6. PubMed ID: 3360051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin.
    Cartel JL; Naudin JC
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):215-9. PubMed ID: 8046260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
    Languillon J; Yawalkar SJ; McDougall AC
    Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinico-pathological study of multidrug regimen in paucibacillary leprosy.
    Kar PK; Jha PK; Panayach JS; Snehi PS
    Indian J Lepr; 1988 Apr; 60(2):235-41. PubMed ID: 3192972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.